Advertisement
Articles
Subscribe to Drug Discovery & Development Articles

The Lead

Promising Malaria and Dengue Vaccines Will Not Defeat Diseases

May 20, 2015 | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | Comments

Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Strongest Statin-Diabetes Link Yet? Not so Fast, Say Some Experts

May 29, 2015 1:50 pm | by Cynthia Fox, Science Editor | Comments

Out of 26,000 healthy people, those taking statins to control cholesterol were a striking 87 percent more likely to become diabetic, said a recent Journal of General Internal Medicine database study. Read more...

TOPICS:

Immuno-Oncolytic Therapies: Compelling Tumor Cells to Mediate Their Own Destruction

May 29, 2015 9:17 am | by Brian Champion, Senior Vice President of R&D at PsiOxus Therapeutics | Comments

The answer may be found in immune-oncolytic viral therapies. Similar to cancer immunotherapy, the concept of oncolytic viruses is not new. The concept was first noted over a century ago when it was discovered that occasionally, tumor regression would follow a viral infection. The search then turned to finding a virus that could “selectively” replicate and kill tumor cells. Read more...

TOPICS:

Genelux Announces Positive Phase 1 Data for Viral-Based Cancer Therapy

May 28, 2015 2:29 pm | by Ryan Bushey, Associate Editor | Comments

Genelux is exploring the area of cancer virotherapy, where one disease is harnessed and used to attack another, with GL-ONC1. Read more...

TOPICS:
Advertisement

Statins May Have Slowed Advanced Prostate Cancer Growth by 10 Months

May 26, 2015 10:08 am | by Cynthia Fox, Science Editor | Comments

When starting androgen deprivation therapy, advanced prostate cancer patients who were taking statins—popular cholesterol-lowering heart drugs—experienced 10 more months of cancer control, according to data published in JAMA Oncology. Read more..

TOPICS:

Injected T Cells from Bone Marrow Treat Multiple Myeloma, Pilot Study Finds

May 21, 2015 1:12 pm | by Stephanie Guzowski, Editor | Comments

In a first small clinical trial of its kind, researchers harnessed T cells from patients’ own bone marrow to treat multiple myeloma and provide immune protection for up to a year, according to a study published this week in Science Translational Medicine. Read more...

TOPICS:

Activists Want to Void Patents on Gilead's High-Priced Hepatitis C Drug

May 20, 2015 12:15 pm | by Ryan Bushey, Associate Editor | Comments

These patents are being challenged all over the world. Read more...

TOPICS:

Abcodia Raises $8M to Launch Ovarian Cancer Screening Test

May 19, 2015 1:14 pm | by Ryan Bushey, Associate Editor | Comments

The test will officially be on the market in the U.S. and U.K. later this year. Read more...

TOPICS:

Global Dyslipidemia Treatment Market Value Will Approach $38B by 2023

May 19, 2015 8:44 am | by Valentina Gburcik, Ph.D., Director of Cardiovascular & Metabolic Disorders, GlobalData | Comments

The global treatment market for dyslipidemia will more than double in value from $15.4 billion in 2013 to an estimated $37.9 billion by 2023. Read more...

TOPICS:
Advertisement

Cancer Institute of NJ Investigates Promising Immunotherapy for Toughest Lung Cancers

May 14, 2015 11:47 am | by Seth Augenstein, Digital Reporter | Comments

Small-cell lung cancer, often caused by smoking, is among the most stubborn diseases in oncology. While it might respond initially to chemotherapy, it often recurs – and comes back even more resistant to treatment. But a new use of a known immunotherapy, bolstering the body’s immune system, is showing some promise against this disease, according to research taking place at the Rutgers Cancer Institute of New Jersey. Read more...

TOPICS:

B Vitamin May Prevent Recurrence of Skin Cancers

May 14, 2015 11:33 am | by Ryan Bushey, Associate Editor | Comments

A study conducted by scientists at Australia’s University of Sydney found that a form of vitamin B3 has the potential to lower the chance of developing skin cancer. Read more...

TOPICS:

AstraZeneca to Focus on Precision Medicine for Asthma, Heart Disease

May 13, 2015 9:50 am | by Ryan Bushey, Associate Editor | Comments

Abbot Laboratories and the Montreal Heart Institute will help the company with this project. Read more..

TOPICS:

The U.S. Looks to Improve on Cuba's Lung Cancer Vaccine

May 12, 2015 8:38 am | by Ryan Bushey, Associate Editor | Comments

The injection is being evaluated as a possible preventative intervention. Read more...

TOPICS:

Tribeca Disruptive Innovation Awards: From Detecting HIV to Nanoscale Imaging

May 11, 2015 3:24 pm | by Cynthia Fox, Science Editor | Comments

In the spirit of its title, this year’s Tribeca Film Festival’s Disruptive Technologies awards ceremony did not distinguish between work that was only simple or complex; only big or small. It focused on work that angled to disrupt the norm, or “transcend limits,” said presenter and Tribeca Film Institute co-founder Craig Hatkoff. Read more...

TOPICS:

GSK, UNC Team Up to Fight HIV

May 11, 2015 10:47 am | by Ryan Bushey, Associate Editor | Comments

Glaxo will spend a total of $20 million over the next five years to fund this endeavor.  Read more...

TOPICS:

Nanotechnology Applications in Drug Delivery

May 8, 2015 4:28 pm | by Michael Morgen, Ph.D., Bend Research Inc., a division of Capsugel Dosage Form Solutions | Comments

In recent years nanotechnology has received significant interest for a wide range of applications, including those within the pharmaceutical industry.  In this area in particular, a number of diverse nano-sized structures have been investigated for drug formulation and delivery. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading